曲美他嗪对心肌缺血大鼠运动耐量的影响研究(3)
[3] 衣紹蕊,孙经武,张明哲,等.曲美他嗪对慢性心力衰竭患者血管内皮功能的影响研究[J].中国全科医学,2014,17(20):2321-2324.
[4] Rossoni LV, Oliveira RA, Caffaro RR, et al. Cardiac benefits of exercise training in aging spontaneously hypertensive rats[J]. J Hypertens, 2011, 29(12):2349-2358.
[5] Jia LL, Kang YM, Wang FX, et al. Exercise training attenuates hypertension and cardiac hypertrophy by modulating neurotransmitters and cytokines in hypothalamic paraventricular nucleus[J] . PLoS One,2014, 9(1): e85481.
[6] Ghadieh AS, Saab B. Evidence for exercise training in the management of hypertension in adults[J]. Can Fam Physician,2015, 61(3): 233-239.
[7] Fagard RH. Exercise therapy in hypertensive cardiovascular disease[J]. Prog Cardiovasc Dis, 2011, 53(6):404-411.
[8] Lee DC, Pate RR, Lavie CJ, et al. Leisure-time running reduces all-cause and cardiovascular mortality risk[J]. JACC, 2014, 64(5):472-481.
[9] Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications[J].Cardiology,2012,122( 1):55-68.
[10] Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3ketoacyl coenzyme A thiolase [J]. Circ Res,2000,86(5):580-588.
(收稿日期:2017-09-15), http://www.100md.com(张奕)
[4] Rossoni LV, Oliveira RA, Caffaro RR, et al. Cardiac benefits of exercise training in aging spontaneously hypertensive rats[J]. J Hypertens, 2011, 29(12):2349-2358.
[5] Jia LL, Kang YM, Wang FX, et al. Exercise training attenuates hypertension and cardiac hypertrophy by modulating neurotransmitters and cytokines in hypothalamic paraventricular nucleus[J] . PLoS One,2014, 9(1): e85481.
[6] Ghadieh AS, Saab B. Evidence for exercise training in the management of hypertension in adults[J]. Can Fam Physician,2015, 61(3): 233-239.
[7] Fagard RH. Exercise therapy in hypertensive cardiovascular disease[J]. Prog Cardiovasc Dis, 2011, 53(6):404-411.
[8] Lee DC, Pate RR, Lavie CJ, et al. Leisure-time running reduces all-cause and cardiovascular mortality risk[J]. JACC, 2014, 64(5):472-481.
[9] Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications[J].Cardiology,2012,122( 1):55-68.
[10] Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3ketoacyl coenzyme A thiolase [J]. Circ Res,2000,86(5):580-588.
(收稿日期:2017-09-15), http://www.100md.com(张奕)